NCT06307574Recruiting
bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment
Source: ClinicalTrials.gov · Last updated 15 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on an education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes on primary and secondary measures will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 12 Feb 2024
- Start date
- 29 Feb 2024
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- University of Arizona
- Diseases
- High blood pressure
- NCT number
- NCT06307574
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 29 Feb 2024 to the primary completion date, 30 Apr 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of dementia
Other
- Lives in assisted living facility or skilled nursing facility
Who the study is looking for
- Age 60+
- Community-dwelling older adults
- Self-reported fluent in English
- Adequate self-reported visual and hearing ability
- Self-reported memory, thinking, or concentration challenges
- Self-manage at least one prescribed antihypertensive medication
- Have and use a smartphone
- No self-reported history of major depression or other mental health diagnoses
- No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease
- TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26
- Willing to participate in the study for at least 4 months
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Illinois Urbana-Champaign Coordinator of this site? Confirm its status | Champaign | United States | Recruiting |
| University of Arizona Coordinator of this site? Confirm its status | Tucson | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.